Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEMISE-MT: Dexmedetomidine Vs Midazolam for Procedural Sedation During Medical Thoracoscopy
NCT07184801Phase 3Recruiting
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Oct 2025
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in Procedural sedation (PS) (2 arms), sponsored by Post Graduate Institute of Medical Education and Research. Primary endpoint: Total amount of rescue medication (sedation or analgesia) required during MT at 6 hours. Started Oct 2025; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Procedural sedation (PS)
Beyond the preview
Go deeper on NCT07184801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07184801.